Jean-Marc Roussel

home / authors / jean-marc-roussel

Jean-Marc Roussel is a member of the USP M&DQ EC.

Articles

Paulista/stock.adobe.com – For high-risk analytical procedures, control-chart monitoring of selected performance data can provide early warning of changes in performance.

Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>

Phil Borman;Amanda Guiraldelli Mahr;Jane Weitzel;Sarah Thompson;Joachim Ermer;Stephanie Sproule;Jean-Marc Roussel;Jaime Marach;Horacio Pappa

Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

Published: August 21st 2024 | Updated: December 26th 2024

Pharmaceutical Technology Editorial Advisory Board

Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics

Published: November 25th 2024 | Updated: December 26th 2024

Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics

Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development

Published: December 20th 2024 | Updated: December 26th 2024

Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development

Europa Perspectives: Helping to Navigate the Regulatory System

Published: February 23rd 2024 | Updated: December 26th 2024

Europa Perspectives: Helping to Navigate the Regulatory System

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.